PGPRX
Price
$24.56
Change
-$0.09 (-0.37%)
Updated
Mar 11 closing price
Net Assets
2.06B
RLBFX
Price
$34.04
Change
-$0.10 (-0.29%)
Updated
Mar 11 closing price
Net Assets
232.94B
Ad is loading...

PGPRX vs RLBFX

Header iconPGPRX vs RLBFX Comparison
Open Charts PGPRX vs RLBFXBanner chart's image
George Putnam Balanced R
Price$24.56
Change-$0.09 (-0.37%)
VolumeN/A
Net Assets2.06B
American Funds American Balanced R5
Price$34.04
Change-$0.10 (-0.29%)
VolumeN/A
Net Assets232.94B
PGPRX vs RLBFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PGPRX vs. RLBFX commentary
Mar 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGPRX is a Hold and RLBFX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLBFX has more cash in the bank: 233B vs. PGPRX (2.06B). RLBFX pays higher dividends than PGPRX: RLBFX (2.19) vs PGPRX (1.67). PGPRX was incepted earlier than RLBFX: PGPRX (22 years) vs RLBFX (23 years). PGPRX (1.18) is less costly to investors than RLBFX (0.30). RLBFX is a more actively managed with annual turnover of: 171.00 vs. PGPRX (80.00). PGPRX has a lower initial minimum investment than RLBFX: PGPRX (0) vs RLBFX (250). PGPRX annual gain was more profitable for investors over the last year : 5.94 vs. RLBFX (4.53). RLBFX return over 5 years is better than : 42.53 vs. PGPRX (38.39).
PGPRXRLBFXPGPRX / RLBFX
Total Expense Ratio1.180.30393%
Annual Report Gross Expense Ratio1.180.30393%
Fund Existence22 years23 years-
Gain YTD-1.355-0.347390%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.06B233B1%
Annual Yield % from dividends1.672.1976%
Returns for 1 year5.944.53131%
Returns for 3 years21.5116.09134%
Returns for 5 years38.3942.5390%
Returns for 10 years62.3554.64114%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RCGHX16.56N/A
N/A
Virtus KAR Health Sciences C
OSPAX9.34N/A
N/A
Invesco SteelPath MLP Alpha R6
BLNIX12.63N/A
N/A
Meeder Balanced Institutional
SSGVX123.86N/A
N/A
State Street Glb All Cap Eq ex-US Idx
CZMGX19.40N/A
N/A
Multi-Manager Growth Strategies Inst